Long-term biochemical control of prostate cancer after standard or hyper-fractionation: Evidence for different outcomes between low–intermediate and high risk patients-Reference-Cited by-同舟云学术

Long-term biochemical control of prostate cancer after standard or hyper-fractionation: Evidence for different outcomes between low–intermediate and high risk patients

Published:2011-12 Issue:3 Volume:101 Page:454-459
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Valdagni Riccardo,Nahum Alan E.,Magnani Tiziana,Italia Corrado,Lanceni Angelo,Montanaro Paolo,Rancati Tiziana,Avuzzi Barbara,Fiorino Claudio

Funder

Fondazione Italo Monzino, Milan

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference46 articles.

1. Higher than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controller trials;Viani;Int J Radiat Oncol Biol Phys,2009

2. A new method for synthesizing radiation dose–response data from multiple trials applied to prostate cancer;Diez;Int J Radiat Oncol Biol Phys,2010

3. A rationale for fractionation for slowly proliferating tumors such as prostatic adenocarcinoma;Fowler;Int J Radiat Oncol Biol Phys,1995

4. Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: results of a dose escalation study;Forman;Int J Radiat Oncol Biol Phys,1996

5. The linear quadratic approach in clinical practice;Bentzen,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age 70 +/– 5 Years and Cancer-Specific Outcomes After Treatment of Localized Prostate Cancer: A Systematic Review;International Journal of Radiation Oncology*Biology*Physics;2023-10

2. A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer;Practical Radiation Oncology;2020-09

3. Hypofractionation in prostate cancer radiotherapy;Translational Cancer Research;2018-07

4. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies;Radiation Oncology;2018-05-16

5. Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I–II Study;Clinical Oncology;2016-08